Drugs / mZINT
last change Oct 2009 re-read 3 minutes ago

mZINT

also known as [123I] mZINT

Diagnostic / imaging agent

Investigated by
Institute for Neurodegenerative Disorders · Molecular NeuroImaging

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00427674 Jan 2007 → Aug 2009 Parkinson disease Institute for Neurodegenerative Disorders Terminated No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as mZINT ClinicalTrials.gov intervention name — accepted as the source's own label NCT00427674 ↗
Known as [123I] mZINT “[123I] mZINT injection and serial dynamic SPECT imaging” NCT00427674 ↗
Modality Diagnostic / imaging agent “as a Brain SPECT Tracer of Serotonin Transporters” NCT00427674 ↗
Route Intravenous “bolus intravenous injection” NCT00427674 ↗